Proton pump inhibitors and the risk of urolithiasis: A Mendelian randomization study. [PDF]
Medicine (Baltimore)Guo J, Chen X, Dou Y, Xiong Y, Zhao T.
europepmc +1 more source
Proton pump inhibitors-induced thrombocytopenia: A systematic literature analysis of case reports. [PDF]
Open Med (Wars)Yue X, Tian H.
europepmc +1 more source
High dose of lansoprazole plus amoxicillin versus high dose of lansoprazole plus amoxicillin and clarithromycin for Helicobacter pylori (H. pylori) infection [PDF]
, 1995 openalex +1 more source
Pharmacokinetics of CYP2C19- and CYP3A4-Metabolized Drugs in Cirrhosis Using a Whole-Body PBPK Approach. [PDF]
PharmaceuticsMu R +5 more
europepmc +1 more source
Long-Term Quality of Life Improvement in Subjects with Healed Erosive Esophagitis: Treatment with Lansoprazole [PDF]
, 2009 Thomas O. Kovacs +5 more
openalex +1 more source
Comparative Efficacy of Potassium-Competitive Acid Blockers (P-CABs) Versus Proton Pump Inhibitors (PPIs) in the Management of Erosive Esophagitis: A Systematic Review. [PDF]
CureusRaza H +8 more
europepmc +1 more source
A Vanished Association Between Proton Pump Inhibitors and Clostridioides Difficile Infection After Minimizing Bias. [PDF]
J Clin MedWu B, He Z, Xu T.
europepmc +1 more source
Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study. [PDF]
J Korean Med SciKim S, Kim JS.
europepmc +1 more source